These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21613799)

  • 1. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.
    Venyo AK; Herring D; Greenwood H; Maloney DJ
    Pan Afr Med J; 2010; 7():20. PubMed ID: 21918707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
    Plage H; Furlano K; Hofbauer S; Weinberger S; Ralla B; Franz A; Fendler A; de Martino M; Roßner F; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Zecha H; Minner S; Simon R; Sauter G; Weischenfeldt J; Klatte T; Schlomm T; Horst D; Schallenberg S
    BMC Urol; 2024 Apr; 24(1):96. PubMed ID: 38658905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
    Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
    Nahar R; Jinnah MSA; Karim SS; Alam MM; Khatun J; Kabir E; Aktar M
    Mymensingh Med J; 2024 Apr; 33(2):461-465. PubMed ID: 38557526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of WNT5A long and short isoforms in non-muscle-invasive bladder urothelial carcinoma.
    Strope AM; Phillips C; Khadgi S; Jenkinson SA; Coschigano KT; Malgor R
    Histol Histopathol; 2024 Jun; 39(6):715-727. PubMed ID: 38445662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
    Madigan MC; Kingsley EA; Cozzi PJ; Delprado WJ; Russell PJ; Li Y
    Cancer Immunol Immunother; 2008 Sep; 57(9):1367-79. PubMed ID: 18273614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
    Boddu VK; Zamzow P; Kramer MW; Merseburger AS; Gorantla SP; Klinger M; Cramer L; Sauer T; Gemoll T; von Bubnoff N; Gieseler F; Darabi M
    Cell Commun Signal; 2024 Feb; 22(1):129. PubMed ID: 38360687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD47 expression in urothelial carcinoma and its correlation with histopathological findings.
    Çoban G; Yıldız P; Şahin N; Ersöz C; Toprak A; Ünver N; Elagöz Ş
    Indian J Cancer; 2023 Oct; 60(4):458-463. PubMed ID: 38078465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
    Sahu D; Lotan Y; Wittmann B; Neri B; Hansel DE
    Cancer Med; 2017 Sep; 6(9):2106-2120. PubMed ID: 28766915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
    Kaczmarek K; Plage H; Furlano K; Hofbauer S; Weinberger S; Ralla B; Franz A; Fendler A; de Martino M; Roßner F; Schallenberg S; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Weischenfeldt J; Klatte T; Schlomm T; Horst D; Zecha H
    Int Urol Nephrol; 2024 Feb; 56(2):499-508. PubMed ID: 37777995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.
    Elsayed AM; Mahmoud EI; Salem MM; Khairy RA
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):637-646. PubMed ID: 38415551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal osseous metaplasia in urothelial carcinoma of the bladder: An unusual and challenging feature. A case report.
    Iglesias de Ussel Galarreta I; Queipo Gutiérrez FJ
    Rev Esp Patol; 2024; 57(2):116-119. PubMed ID: 38599730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on immunohistochemical expression of HER2/Neu and p63 and its association with grade and invasiveness in case of bladder carcinoma.
    Sinha S; Choudhury S; Mishra J; Kundu G; Bera MK; Mondol PP
    Urologia; 2024 May; 91(2):284-288. PubMed ID: 38390685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominative role of MMP-14 over MMP-15 in human urinary bladder carcinoma on the basis of its enhanced specific activity.
    Kudelski J; Młynarczyk G; Darewicz B; Bruczko-Goralewska M; Romanowicz L
    Medicine (Baltimore); 2020 Feb; 99(7):e19224. PubMed ID: 32049862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking-related OLC1 overexpression associated with poor prognosis in bladder urothelial carcinoma.
    Chen H; Cai Z; Dong X; Chen W; Cao C; Zheng S; Wu J; Zhong D; Cheng S; Gao Y; Shou J
    Life Sci; 2024 Aug; 351():122821. PubMed ID: 38880167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Several key and difficult issues related to the grading of urothelial carcinoma of urinary bladder].
    Zhao M; Teng XD; He HY; Cheng L
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):773-776. PubMed ID: 39103256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs.
    Murai R; Yoshida Y; Muraguchi T; Nishimoto E; Morioka Y; Kitayama H; Kondoh S; Kawazoe Y; Hiraoka M; Uesugi M; Noda M
    Oncotarget; 2010 Aug; 1(4):252-264. PubMed ID: 21304177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas.
    Müller JH; Plage H; Elezkurtaj S; Mandelkow T; Huang Z; Lurati MCJ; Raedler JB; Debatin NF; Vettorazzi E; Samtleben H; Hofbauer S; Furlano K; Neymeyer J; Goranova I; Ralla B; Weinberger S; Horst D; Roßner F; Schallenberg S; Marx AH; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Lennartz M; Minner S; Simon R; Sauter G; Zecha H; Schlomm T; Bady E
    Front Oncol; 2023; 13():1342367. PubMed ID: 38282671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs.
    Yuan J; Li W; Zhu J; Deng S; Tao X
    Int J Clin Exp Pathol; 2020; 13(3):501-508. PubMed ID: 32269688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.